Intracellular free calcium ion ([Ca²⁺]i)

Intracellular free calcium (Ca²⁺) serves as a universal and versatile second messenger that regulates a vast array of cellular processes. In resting cells, the concentration of free cytosolic calcium is maintained at approximately 100 nM, which is roughly 10,000 times lower than the extracellular concentration, primarily through the activity of ATP-dependent pumps and ion exchangers (Clapham, 2007, Cell). Rapid increases in [Ca²⁺]i occur in response to physiological stimuli via influx through various ion channels in the plasma membrane or release from intracellular stores such as the endoplasmic reticulum. These calcium transients trigger specific downstream effects including muscle contraction, neurotransmitter exocytosis, and the activation of calcium-dependent enzymes like protein kinase C and calmodulin-dependent kinases (StatPearls, Physiology, Calcium). Chronic dysregulation of intracellular calcium homeostasis is a hallmark of several pathologies, particularly in the cardiovascular and nervous systems, where calcium overload can lead to cell death or impaired signaling. While intracellular calcium itself is a chemical species rather than a protein target, it is the functional endpoint for numerous classes of drugs, including calcium channel blockers and calcium sensitizers, which aim to restore normal signaling patterns in disease states.

Other names

Cytosolic calciumFree cytosolic calciumCytoplasmic calciumSecond messenger calcium

Drugs modulate intracellular calcium levels by inhibiting or activating plasma membrane calcium channels (e.g., L-type channels), modulating sarcoplasmic/endoplasmic reticulum calcium-ATPase (SERCA) pumps, or regulating release through ryanodine receptors (RyR) and inositol trisphosphate (IP3) receptors (Berridge et al., 2000, Nature Reviews Molecular Cell Biology).